PATENT CLAIM ANALYSIS

Application Number: 15956172
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "574000"]

Abstract:
This present invention provides gemcabene pharmaceutically acceptable salts having a PSD90 of 35 μm to about 90 μm, methods for purifying crude gemcabene, pharmaceutically acceptable salts of purified gemcabene, pharmaceutical compositions of a gemcabene pharmaceutically acceptable salt and therapeutic and prophylactic methods useful for various conditions, including dyslipidemia.

Claim (Index 11):
A pharmaceutically acceptable salt of the gemcabene of  claim 10 .

Metadata:
- Claim Count in Document: 1.0
- Percentile: 91.0
- Lexical Diversity: 1.51429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15416911', '15814557', '14921796', '13168629', '15215329']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.720215647065395
- 35 USC 102 Novelty (BERT): 0.5253178034316814
- Combined Prediction Score: 0.7007258627020236
- Mean Citation Score: 245.865048
- Max Citation Score: 299.6387
- Similarity Product: 173.83025062333343

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test